About AbbVie Inc (ABBV)
Abbvie is a research-based pharmaceutical company which was the result of a spin-off from fellow dividend pharma stock Abbott Labarotories in January 2013. The company has a solid lineup of products and is in the Phase 3 for a hepatitus C treatment.
For more info: Abbvie Website, Abbvie Investor Relations
Recent Dividend Posts About AbbVie Inc (ABBV)
–Abbvie Inc. (ABBV) Dividend Stock Analysis @DividendGrowthStocks
–Abbvie Inc. (ABBV) Dividend Stock Analysis @DividendGrowthStocks
–Abbvie Inc. (ABBV) Dividend Stock Analysis @DividendGrowthStocks
-more coming soon
AbbVie Inc (ABBV)
[stocks s=”ABBV”] | ![]() |